A novel AGGF1-PDGFRβ fusion in pediatric T-cell acute lymphoblastic leukemia

Matthew S. Zabriskie; Orlando Antelope; Anupam R. Verma; Lauren R. Draper; Christopher A. Eide; Anthony D. Pomicter; Thai Hoa Tran; Brian J. Druker; Jeffrey W. Tyner; Rodney R. Miles; James M. Graham; Jae Yeon Hwang; Katherine E. Varley; Reha M. Toydemir; Michael W. Deininger; Elizabeth A. Raetz; Thomas O’Hare

doi:10.3324/haematol.2017.165282

A novel AGGF1-PDGFRβ fusion in pediatric T-cell acute lymphoblastic leukemia

Matthew S. Zabriskie, Orlando Antelope, Anupam R. Verma, Lauren R. Draper, Christopher A. Eide, Anthony D. Pomicter, Thai Hoa Tran, Brian J. Druker, Jeffrey W. Tyner, Rodney R. Miles, James M. Graham, Jae Yeon Hwang, Katherine E. Varley, Reha M. Toydemir, Michael W. Deininger, Elizabeth A. Raetz, Thomas O’Hare

Knight Cancer Institute

Research output: Contribution to journal › Comment/debate › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	e87-e91
Journal	Haematologica
Volume	103
Issue number	2
DOIs	https://doi.org/10.3324/haematol.2017.165282
State	Published - Jan 31 2018

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2017.165282

Cite this

Zabriskie, M. S., Antelope, O., Verma, A. R., Draper, L. R., Eide, C. A., Pomicter, A. D., Tran, T. H., Druker, B. J., Tyner, J. W., Miles, R. R., Graham, J. M., Hwang, J. Y., Varley, K. E., Toydemir, R. M., Deininger, M. W., Raetz, E. A., & O’Hare, T. (2018). A novel AGGF1-PDGFRβ fusion in pediatric T-cell acute lymphoblastic leukemia. Haematologica, 103(2), e87-e91. https://doi.org/10.3324/haematol.2017.165282

A novel AGGF1-PDGFRβ fusion in pediatric T-cell acute lymphoblastic leukemia. / Zabriskie, Matthew S.; Antelope, Orlando; Verma, Anupam R.; Draper, Lauren R.; Eide, Christopher A.; Pomicter, Anthony D.; Tran, Thai Hoa; Druker, Brian J.; Tyner, Jeffrey W.; Miles, Rodney R.; Graham, James M.; Hwang, Jae Yeon; Varley, Katherine E.; Toydemir, Reha M.; Deininger, Michael W.; Raetz, Elizabeth A.; O’Hare, Thomas.

In: Haematologica, Vol. 103, No. 2, 31.01.2018, p. e87-e91.

Research output: Contribution to journal › Comment/debate › peer-review

Zabriskie, MS, Antelope, O, Verma, AR, Draper, LR, Eide, CA, Pomicter, AD, Tran, TH, Druker, BJ , Tyner, JW, Miles, RR, Graham, JM, Hwang, JY, Varley, KE, Toydemir, RM, Deininger, MW, Raetz, EA & O’Hare, T 2018, 'A novel AGGF1-PDGFRβ fusion in pediatric T-cell acute lymphoblastic leukemia', Haematologica, vol. 103, no. 2, pp. e87-e91. https://doi.org/10.3324/haematol.2017.165282

Zabriskie, Matthew S. ; Antelope, Orlando ; Verma, Anupam R. ; Draper, Lauren R. ; Eide, Christopher A. ; Pomicter, Anthony D. ; Tran, Thai Hoa ; Druker, Brian J. ; Tyner, Jeffrey W. ; Miles, Rodney R. ; Graham, James M. ; Hwang, Jae Yeon ; Varley, Katherine E. ; Toydemir, Reha M. ; Deininger, Michael W. ; Raetz, Elizabeth A. ; O’Hare, Thomas. / A novel AGGF1-PDGFRβ fusion in pediatric T-cell acute lymphoblastic leukemia. In: Haematologica. 2018 ; Vol. 103, No. 2. pp. e87-e91.

@article{0869fe39b6f545fda91c26290958404f,

title = "A novel AGGF1-PDGFRβ fusion in pediatric T-cell acute lymphoblastic leukemia",

author = "Zabriskie, {Matthew S.} and Orlando Antelope and Verma, {Anupam R.} and Draper, {Lauren R.} and Eide, {Christopher A.} and Pomicter, {Anthony D.} and Tran, {Thai Hoa} and Druker, {Brian J.} and Tyner, {Jeffrey W.} and Miles, {Rodney R.} and Graham, {James M.} and Hwang, {Jae Yeon} and Varley, {Katherine E.} and Toydemir, {Reha M.} and Deininger, {Michael W.} and Raetz, {Elizabeth A.} and Thomas O{\textquoteright}Hare",

note = "Funding Information: 1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; 2Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Utah, Salt Lake City, UT; 3Knight Cancer Institute, Oregon Health & Science University, Portland, OR; 4Howard Hughes Medical Institute, Portland, OR; 5Helen Diller Family Cancer Research Center, Benioff Children{\textquoteright}s Hospital, San Francisco, CA; 6Department of Pathology, University of Utah, Salt Lake City, UT; 7Department of Oncological Sciences, University of Utah, Salt Lake City, UT; 8Department of Pediatrics, Division of Medical Genetics, University of Utah, Salt Lake City, UT and 9Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA *MSZ and OA contributed equally. ξEAR and TO contributed equally Acknowledgments: we acknowledge the Pediatric Cancer Program Biobank with support from the Primary Children's Hospital and Intermountain Healthcare Foundations and the Children's Oncology Group Cell Bank. We acknowledge Amber D. Bowler for technical assistance. Funding Information: Funding: research reported in this publication was supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under Award Number R01CA178397. The authors acknowledge support of funds in conjunction with the NIH / NCI Cancer Center Support Grant P30CA042014 awarded to the Huntsman Cancer Institute. JWT was supported by The Leukemia & Lymphoma Society, the V Foundation for Cancer Research, the Gabrielle{\textquoteright}s Angel Foundation for Cancer Research, and the NCI (5R00CA151457-04; 1R01CA183947-01). BJD is an investigator for the Howard Hughes Medical Institute and is also supported by the NCI (2R01CA065823-21A1). JWT receives research support from Aptose, Array, AstraZeneca, Constellation, Genentech, Gilead, Incyte, Janssen, Seattle Genetics, Syros, Takeda; Scientific Advisory Board for Leap Oncology. B.J.D.{\textquoteright}s institution (OHSU) receives clinical trial funding from Novartis, Bristol-Myers Squibb, and ARIAD.",

year = "2018",

month = jan,

day = "31",

doi = "10.3324/haematol.2017.165282",

language = "English (US)",

volume = "103",

pages = "e87--e91",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "2",

}

TY - JOUR

T1 - A novel AGGF1-PDGFRβ fusion in pediatric T-cell acute lymphoblastic leukemia

AU - Zabriskie, Matthew S.

AU - Antelope, Orlando

AU - Verma, Anupam R.

AU - Draper, Lauren R.

AU - Eide, Christopher A.

AU - Pomicter, Anthony D.

AU - Tran, Thai Hoa

AU - Druker, Brian J.

AU - Tyner, Jeffrey W.

AU - Miles, Rodney R.

AU - Graham, James M.

AU - Hwang, Jae Yeon

AU - Varley, Katherine E.

AU - Toydemir, Reha M.

AU - Deininger, Michael W.

AU - Raetz, Elizabeth A.

AU - O’Hare, Thomas

N1 - Funding Information: 1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; 2Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Utah, Salt Lake City, UT; 3Knight Cancer Institute, Oregon Health & Science University, Portland, OR; 4Howard Hughes Medical Institute, Portland, OR; 5Helen Diller Family Cancer Research Center, Benioff Children’s Hospital, San Francisco, CA; 6Department of Pathology, University of Utah, Salt Lake City, UT; 7Department of Oncological Sciences, University of Utah, Salt Lake City, UT; 8Department of Pediatrics, Division of Medical Genetics, University of Utah, Salt Lake City, UT and 9Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA *MSZ and OA contributed equally. ξEAR and TO contributed equally Acknowledgments: we acknowledge the Pediatric Cancer Program Biobank with support from the Primary Children's Hospital and Intermountain Healthcare Foundations and the Children's Oncology Group Cell Bank. We acknowledge Amber D. Bowler for technical assistance. Funding Information: Funding: research reported in this publication was supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under Award Number R01CA178397. The authors acknowledge support of funds in conjunction with the NIH / NCI Cancer Center Support Grant P30CA042014 awarded to the Huntsman Cancer Institute. JWT was supported by The Leukemia & Lymphoma Society, the V Foundation for Cancer Research, the Gabrielle’s Angel Foundation for Cancer Research, and the NCI (5R00CA151457-04; 1R01CA183947-01). BJD is an investigator for the Howard Hughes Medical Institute and is also supported by the NCI (2R01CA065823-21A1). JWT receives research support from Aptose, Array, AstraZeneca, Constellation, Genentech, Gilead, Incyte, Janssen, Seattle Genetics, Syros, Takeda; Scientific Advisory Board for Leap Oncology. B.J.D.’s institution (OHSU) receives clinical trial funding from Novartis, Bristol-Myers Squibb, and ARIAD.

PY - 2018/1/31

Y1 - 2018/1/31

UR - http://www.scopus.com/inward/record.url?scp=85041493678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041493678&partnerID=8YFLogxK

U2 - 10.3324/haematol.2017.165282

DO - 10.3324/haematol.2017.165282

M3 - Comment/debate

C2 - 29284681

AN - SCOPUS:85041493678

VL - 103

SP - e87-e91

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 2

ER -